2024 Aug | Opal Results of Annual Meeting
2024 Jul | Notice of of General Meeting
2024 Jul | Company Update and EOFY 2024 Information
2024 Jun | Notice of General Meeting
2024 Jun | Letter to Shareholders
2024 May | Capital Raising and Update
2024 Apr | Half-year Financial Report
2024 Mar | Extension of Closing Date of Capital Raising – Information Memorandum
2023 Nov | Opal Managing Director Presentation
2023 Nov | Opal Results of Annual General Meeting
2023 Nov | NOTICE Notice of AGM + Proxy Form
2023 Oct | Extension of Closing Date of Capital Raising – Information Memorandum
2023 | Sep Accountant Certification
2023 Sep | Share Application Form
2023 Sep | Opal BioSciences Information Memorandum
2023 Sep | Opal capital raise for growth strategy | IM Announcement
2023 Aug | Update and EOFY 2023 Information
2023 Jul | Opal Biosciences awarded Investment Attraction Fund grant by WA government
2023 June | Proposed acquisition of specialist formulation company Formulytica
2023 May | Opal Half Year financials FY21
2022 Opal AGM
2022 Oct | Extension of Time for Notification of Interest in a Placement
2022 Sep | Exercise of Options and Intention to Offer a Placement
2022 Aug | EOFY 2022 Information
2022 June | Shareholder Update
2022 May | Board changes announced
2021 Opal AGM
2021 Nov | Board changes announced
2021 Sep | Opal Update and EOFY information
2021 Jul | Biotech Precinct Progress and Withdrawal of Capital Raising
2021 Jun | Formulytica Files New International Patent
2021 Jun | Opal Biosciences Leads Proposal for Biotech Precinct
2021 Jun | Opal Extension of Capital Raise
2021 Jun | Formulytica and Biointelect announce Strategic Partnership
2021 Jun | Growth of Formulytica client base
2021 May| Opal acquisition of Formulytica – Capital raising
2021 May| Opal Biosciences 2021 Information Memorandum
2021 May | Opal’s acquisition of specialist formulation company Formulytica
2019 Nov | AGM 2019 Managing Director presentation
2019 Nov | AGM 2019 Chairman’s Address
2019 Sep | Opal option exercise fuels development plan
2019 Aug | Opal partners in new ARC Research Hub
2019 Mar | Opal Releases Half Year Results Announcement – 31 Dec 2018
2019 Mar | Opal Half-year Financial Report – 31 Dec 2018
2018 Opal Joins Global Antimicrobial Challenge
2018 Opal AGM CEO Presentation
2018 Opal AGM Results of Meeting
2018 Opal AGM Chairman’s Address
2018 Opal Biosciences 2018 Annual Report
2018 Opal Biosciences Notice of Meeting and Proxy Form
2018 August | Opal New Board Addition
2018 July | Opal Information Memorandum Announcement
2018 July | Opal Information Memorandum Document
2018 July | Opal July Presentation
2018 May | BioDiem receives Innovation Connections grant for Opal work
2018 Apr | Half-year Financial Report – 31 Dec 2017
2018 | Completion of Placement and Board change